These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31739809)

  • 1. Psychiatric management of anti-NMDAR encephalitis: a cohort analysis.
    Warren N; O'Gorman C; McKeon G; Swayne A; Blum S; Siskind D
    Psychol Med; 2021 Feb; 51(3):435-440. PubMed ID: 31739809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosis and catatonia as presenting features of anti-N-methyl-D-aspartate (anti-NMDA) receptor encephalitis.
    Chatterjee SS; Ghosal MK; Mitra S
    Asian J Psychiatr; 2017 Jun; 27():112. PubMed ID: 28558879
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions.
    Kuppuswamy PS; Takala CR; Sola CL
    Gen Hosp Psychiatry; 2014; 36(4):388-91. PubMed ID: 24731834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-
    Sarkis RA; Coffey MJ; Cooper JJ; Hassan I; Lennox B
    J Neuropsychiatry Clin Neurosci; 2019; 31(2):137-142. PubMed ID: 30561283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and CSF Anti-NMDAR Antibody Testing in Psychiatry.
    Warren N; Swayne A; Siskind D; O'Gorman C; Prain K; Gillis D; Blum S
    J Neuropsychiatry Clin Neurosci; 2020; 32(2):154-160. PubMed ID: 31530118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescents and Young Adults With Anti-N-methyl-D-aspartate Receptor Encephalitis With Excited Catatonia: Literature Review and 2 Illustrative Cases.
    Levy E; Reinoso P; Shoaib H; Drucker J; Ashurova M; Sanghani S; Petrides G; Jimenez X
    J Acad Consult Liaison Psychiatry; 2023; 64(2):177-182. PubMed ID: 35948253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catatonia in Adolescence: First Onset Psychosis or Anti-NMDAr Encephalitis?
    Averna R; Battaglia C; Labonia M; Riccioni A; Vicari S
    Clin Neuropharmacol; 2019; 42(4):136-138. PubMed ID: 31157633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-NMDA receptor encephalitis presenting as postpartum psychosis-a clinical description and review.
    Reddy MSS; Thippeswamy H; Ganjekar S; Nagappa M; Mahadevan A; Arvinda HR; Chandra PS; Taly AB
    Arch Womens Ment Health; 2018 Aug; 21(4):465-469. PubMed ID: 29417305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute psychosis due to non-paraneoplastic anti-NMDA-receptor encephalitis in a teenage girl: Case report.
    Kramina S; Kevere L; Bezborodovs N; Purvina S; Rozentals G; Strautmanis J; Viksna Z
    Psych J; 2015 Dec; 4(4):226-30. PubMed ID: 26663628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-NMDA receptor encephalitis: a cause of acute psychosis and catatonia.
    Ryan SA; Costello DJ; Cassidy EM; Brown G; Harrington HJ; Markx S
    J Psychiatr Pract; 2013 Mar; 19(2):157-61. PubMed ID: 23507817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis.
    Warren N; Siskind D; O'Gorman C
    Acta Psychiatr Scand; 2018 Nov; 138(5):401-408. PubMed ID: 29992532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The validity of atypical psychosis diagnostic criteria to detect anti-NMDA receptor encephalitis with psychiatric symptoms.
    Hinotsu K; Miyaji C; Yada Y; Kawai H; Sakamoto S; Okahisa Y; Tsutsui K; Kanbayashi T; Tanaka K; Takao S; Kishi Y; Takaki M; Yamada N
    Schizophr Res; 2022 Oct; 248():292-299. PubMed ID: 36130472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catatonia secondary to anti-N-methyl-D-aspartate receptor (NMDAr) encephalitis: a review.
    Marques Macedo I; Gama Marques J
    CNS Spectr; 2020 Aug; 25(4):475-492. PubMed ID: 31663486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red flags for suspecting anti-NMDAr encephalitis in a first psychotic episode: report of two cases.
    Restrepo Martínez M; Paola Bautista G; Espínola-Nadurille M; Bayliss L
    Rev Colomb Psiquiatr (Engl Ed); 2019; 48(2):127-130. PubMed ID: 30981326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case of New Onset Psychosis in a Young Woman with Minimal Response to Risperidone, Ultimately Diagnosed with N-Methyl-D-Aspartate Receptor Encephalitis: A Review of this Under-Recognized Condition.
    Spiegel DR; Zaki N
    Clin Schizophr Relat Psychoses; 2015; 9(3):135-40. PubMed ID: 23773888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia after remission of anti-NMDA receptor encephalitis.
    Yasuda K; Uenishi S; Sakamoto H; Hori K; Koh J; Takahashi S
    Asian J Psychiatr; 2022 Apr; 70():103027. PubMed ID: 35180463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric Phenotypes of Pediatric Patients With Seropositive Autoimmune Encephalitis.
    Adams AV; Van Mater H; Gallentine W; Mooneyham GC
    Hosp Pediatr; 2021 Jul; 11(7):743-750. PubMed ID: 34103402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catatonia in adult anti-NMDAR encephalitis: an observational cohort study.
    Wu H; Wu C; Zhou Y; Huang S; Zhu S
    BMC Psychiatry; 2023 Feb; 23(1):94. PubMed ID: 36750806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-NMDAR encephalitis: a new, severe and challenging enduring entity.
    van de Riet EH; Esseveld MM; Cuypers L; Schieveld JN
    Eur Child Adolesc Psychiatry; 2013 May; 22(5):319-23. PubMed ID: 23250735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining the Features of Neuroleptic Malignant Syndrome in Anti-NMDA Receptor Encephalitis: A Case-Control Study.
    Ramirez-Bermudez J; Restrepo-Martinez M; Espinola-Nadurille M; Martinez-Angeles V; Lopez-Hernandez JC; Hernandez-Vanegas LE; Martinez-Carrillo F; Ruiz-Garcia R; Rivas-Alonso V; Flores-Rivera J; Pollak TA
    J Acad Consult Liaison Psychiatry; 2024; 65(3):222-230. PubMed ID: 38151160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.